Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
100.00%
Operating Margin
15.53%
Net Margin
11.02%
Efficiency Metrics
Revenue per Expense Ratio
1.14
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
15.87%
Income Tax Rate
20.60%
EPS
10.0600000000
Balance Sheet Analysis
Current Ratio
2,707,000,000.0
Cash Ratio
1,746,000,000.0
Working Capital
$2.71B
Debt to Equity
0.35
Debt to Assets
4.95%
Equity Ratio
14.29%
Cash Flow Analysis
Operating Cash Flow Ratio
25.48%
Free Cash Flow Ratio
24.55%
CapEx to Revenue
0.93%
Dividends Paid
$684.00M
Stock Buybacks
$213.00M
Total Shareholder Returns
$897.00M
Cash Position Change
40.48%
Detailed Growth Metrics
Core Performance
Revenue
9.77%
Net Income
-5.12%
EPS
-4.64%
Operating Income
-0.58%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
-4,130.56%
Operating Cash Flow
70.86%
Free Cash Flow
84.63%
Balance Sheet Health
Assets
3.32%
Debt
-1.40%
Book Value per Share
5.58%
Inventory
0.00%
Shareholder Returns
Dividends per Share
-43.34%
Shares Outstanding
-0.47%
Long Term Trends
3Y Revenue/Share
2.33%
5Y Revenue/Share
13.57%
3Y Dividend/Share
114.46%
5Y Dividend/Share
82.42%